Crossmark

Duration of anticoagulant therapy after pulmonary embolism can be a tough decision

Crossref DOI link: https://doi.org/10.1016/j.arbr.2019.11.018

Published Print: 2020-10

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Quezada, Andrés

Jiménez, David
License Information

Text and Data Mining valid from 2020-10-01
More Information

This article is maintained by: Elsevier

Article Title: Duration of anticoagulant therapy after pulmonary embolism can be a tough decision

Journal Title: Archivos de Bronconeumología (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.arbr.2019.11.018

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.arbres.2019.11.007

Content Type: simple-article

Copyright: © 2019 SEPAR. Published by Elsevier España, S.L.U. All rights reserved.